 Allison Kempe
Concepts (534)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccination | 73 | 2022 | 1202 | 15.150 |
Why?
| | Influenza Vaccines | 37 | 2021 | 497 | 10.020 |
Why?
| | Reminder Systems | 25 | 2021 | 159 | 8.790 |
Why?
| | Immunization Programs | 31 | 2021 | 204 | 8.720 |
Why?
| | Attitude of Health Personnel | 40 | 2021 | 970 | 8.190 |
Why?
| | Influenza, Human | 28 | 2021 | 543 | 8.050 |
Why?
| | Practice Patterns, Physicians' | 39 | 2021 | 1175 | 7.240 |
Why?
| | Papillomavirus Vaccines | 20 | 2021 | 222 | 6.630 |
Why?
| | Immunization | 27 | 2021 | 397 | 6.630 |
Why?
| | Physicians, Primary Care | 15 | 2021 | 222 | 6.180 |
Why?
| | Pediatrics | 41 | 2021 | 982 | 6.050 |
Why?
| | Parents | 34 | 2023 | 1181 | 5.690 |
Why?
| | Vaccines | 23 | 2021 | 375 | 5.620 |
Why?
| | Health Knowledge, Attitudes, Practice | 28 | 2021 | 1168 | 5.530 |
Why?
| | Physicians, Family | 14 | 2021 | 201 | 3.990 |
Why?
| | Papillomavirus Infections | 14 | 2021 | 261 | 3.990 |
Why?
| | Pediatricians | 9 | 2022 | 122 | 3.700 |
Why?
| | School Health Services | 15 | 2018 | 206 | 3.700 |
Why?
| | Attitude to Health | 12 | 2020 | 398 | 3.680 |
Why?
| | Primary Health Care | 27 | 2023 | 1502 | 3.560 |
Why?
| | Immunization Schedule | 15 | 2021 | 183 | 3.070 |
Why?
| | Vaccination Refusal | 6 | 2021 | 69 | 2.890 |
Why?
| | Health Care Surveys | 26 | 2021 | 541 | 2.820 |
Why?
| | Pneumococcal Vaccines | 8 | 2021 | 131 | 2.780 |
Why?
| | Child | 107 | 2023 | 18401 | 2.670 |
Why?
| | Infant | 73 | 2023 | 7943 | 2.560 |
Why?
| | Colorado | 60 | 2021 | 4090 | 2.540 |
Why?
| | Physicians | 15 | 2022 | 765 | 2.500 |
Why?
| | Family Practice | 17 | 2018 | 426 | 2.480 |
Why?
| | Humans | 222 | 2023 | 114045 | 2.420 |
Why?
| | Insurance, Health, Reimbursement | 6 | 2018 | 88 | 2.390 |
Why?
| | Patient Acceptance of Health Care | 18 | 2021 | 675 | 2.340 |
Why?
| | United States | 71 | 2021 | 12137 | 2.340 |
Why?
| | Adolescent | 83 | 2023 | 17800 | 2.240 |
Why?
| | Surveys and Questionnaires | 36 | 2022 | 4595 | 2.190 |
Why?
| | Female | 136 | 2021 | 59324 | 2.140 |
Why?
| | Male | 130 | 2021 | 55396 | 2.130 |
Why?
| | Child, Preschool | 61 | 2023 | 9114 | 2.100 |
Why?
| | Herpes Zoster Vaccine | 7 | 2022 | 159 | 2.090 |
Why?
| | Sepsis | 7 | 2023 | 507 | 1.880 |
Why?
| | Rotavirus Vaccines | 5 | 2021 | 48 | 1.840 |
Why?
| | Vaccination Coverage | 4 | 2021 | 63 | 1.840 |
Why?
| | Child Health Services | 10 | 2015 | 175 | 1.780 |
Why?
| | Meningococcal Vaccines | 5 | 2018 | 48 | 1.750 |
Why?
| | Text Messaging | 6 | 2021 | 152 | 1.540 |
Why?
| | Rotavirus Infections | 4 | 2021 | 50 | 1.530 |
Why?
| | Mumps | 2 | 2022 | 23 | 1.520 |
Why?
| | Medicaid | 6 | 2021 | 404 | 1.510 |
Why?
| | Ureteral Obstruction | 4 | 2021 | 54 | 1.490 |
Why?
| | Herpes Zoster | 4 | 2022 | 330 | 1.420 |
Why?
| | Organ Transplantation | 4 | 2023 | 159 | 1.420 |
Why?
| | Adult | 57 | 2023 | 30375 | 1.410 |
Why?
| | Gastrostomy | 3 | 2016 | 89 | 1.340 |
Why?
| | Nervous System Diseases | 4 | 2021 | 254 | 1.340 |
Why?
| | Middle Aged | 45 | 2021 | 26605 | 1.300 |
Why?
| | Fundoplication | 3 | 2016 | 51 | 1.300 |
Why?
| | Health Care Costs | 4 | 2017 | 381 | 1.280 |
Why?
| | Emergency Service, Hospital | 13 | 2023 | 1815 | 1.270 |
Why?
| | Adolescent Health Services | 3 | 2015 | 68 | 1.230 |
Why?
| | Shock, Septic | 2 | 2021 | 185 | 1.210 |
Why?
| | Triage | 7 | 2007 | 197 | 1.190 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 6 | 2019 | 89 | 1.190 |
Why?
| | Treatment Refusal | 4 | 2018 | 85 | 1.190 |
Why?
| | Data Collection | 17 | 2020 | 618 | 1.170 |
Why?
| | Guideline Adherence | 8 | 2020 | 489 | 1.160 |
Why?
| | Gynecology | 3 | 2019 | 163 | 1.160 |
Why?
| | Urban Population | 7 | 2019 | 396 | 1.150 |
Why?
| | Patient-Centered Care | 7 | 2023 | 470 | 1.130 |
Why?
| | Patient Readmission | 3 | 2019 | 607 | 1.130 |
Why?
| | Practice Guidelines as Topic | 14 | 2021 | 1381 | 1.120 |
Why?
| | Chronic Disease | 8 | 2021 | 1577 | 1.110 |
Why?
| | Clinical Competence | 4 | 2018 | 882 | 1.110 |
Why?
| | Insurance, Health | 6 | 2016 | 243 | 1.100 |
Why?
| | Internal Medicine | 5 | 2014 | 211 | 1.100 |
Why?
| | Rural Population | 7 | 2019 | 443 | 1.100 |
Why?
| | Research Design | 4 | 2023 | 919 | 1.090 |
Why?
| | Respiratory Syncytial Virus Infections | 2 | 2018 | 97 | 1.080 |
Why?
| | Delivery of Health Care | 7 | 2022 | 828 | 1.050 |
Why?
| | State Health Plans | 5 | 2005 | 32 | 1.030 |
Why?
| | Professional-Family Relations | 3 | 2016 | 131 | 1.020 |
Why?
| | Meningococcal Infections | 2 | 2018 | 20 | 0.990 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 285 | 0.980 |
Why?
| | Quality of Health Care | 3 | 2023 | 572 | 0.940 |
Why?
| | Health Services Research | 5 | 2018 | 373 | 0.940 |
Why?
| | Physician-Patient Relations | 3 | 2019 | 459 | 0.930 |
Why?
| | Telephone | 7 | 2010 | 152 | 0.930 |
Why?
| | Pneumococcal Infections | 3 | 2018 | 91 | 0.910 |
Why?
| | Preventive Health Services | 2 | 2016 | 134 | 0.900 |
Why?
| | Measles | 2 | 2022 | 38 | 0.900 |
Why?
| | Kidney Pelvis | 2 | 2021 | 19 | 0.900 |
Why?
| | Medication Therapy Management | 2 | 2023 | 67 | 0.870 |
Why?
| | Health Services Accessibility | 8 | 2019 | 756 | 0.860 |
Why?
| | General Practitioners | 2 | 2021 | 23 | 0.860 |
Why?
| | Hospitalization | 6 | 2019 | 1762 | 0.850 |
Why?
| | Retrospective Studies | 27 | 2023 | 12521 | 0.850 |
Why?
| | Liver Transplantation | 3 | 2019 | 695 | 0.840 |
Why?
| | Immunocompromised Host | 3 | 2019 | 192 | 0.830 |
Why?
| | New York | 5 | 2020 | 105 | 0.820 |
Why?
| | Infant, Newborn | 19 | 2021 | 5038 | 0.810 |
Why?
| | Information Dissemination | 2 | 2015 | 185 | 0.810 |
Why?
| | Hospitals, Pediatric | 8 | 2023 | 478 | 0.800 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 124 | 0.790 |
Why?
| | Gastroesophageal Reflux | 2 | 2016 | 229 | 0.790 |
Why?
| | Rubella | 1 | 2022 | 21 | 0.780 |
Why?
| | Urologic Surgical Procedures | 3 | 2021 | 94 | 0.780 |
Why?
| | Algorithms | 4 | 2019 | 1469 | 0.770 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 15 | 0.770 |
Why?
| | Advisory Committees | 4 | 2021 | 207 | 0.770 |
Why?
| | Medically Uninsured | 7 | 2014 | 122 | 0.770 |
Why?
| | Hepatitis B Vaccines | 4 | 2010 | 46 | 0.770 |
Why?
| | Poverty | 8 | 2018 | 440 | 0.760 |
Why?
| | Insurance Coverage | 5 | 2018 | 199 | 0.760 |
Why?
| | Community Health Centers | 3 | 2018 | 53 | 0.750 |
Why?
| | Motivation | 3 | 2023 | 488 | 0.750 |
Why?
| | Cost-Benefit Analysis | 8 | 2019 | 544 | 0.750 |
Why?
| | Prescription Drug Overuse | 1 | 2020 | 11 | 0.720 |
Why?
| | Refusal to Treat | 1 | 2020 | 18 | 0.710 |
Why?
| | Patient Participation | 3 | 2012 | 348 | 0.710 |
Why?
| | Decision Making | 6 | 2019 | 760 | 0.710 |
Why?
| | Quality Improvement | 5 | 2020 | 944 | 0.700 |
Why?
| | Patient Admission | 2 | 2019 | 175 | 0.700 |
Why?
| | Standing Orders | 1 | 2020 | 11 | 0.690 |
Why?
| | Reimbursement Mechanisms | 3 | 2018 | 76 | 0.690 |
Why?
| | Polypharmacy | 2 | 2023 | 74 | 0.670 |
Why?
| | Hydronephrosis | 2 | 2021 | 28 | 0.670 |
Why?
| | Emergencies | 3 | 2007 | 143 | 0.670 |
Why?
| | Symptom Assessment | 1 | 2020 | 119 | 0.660 |
Why?
| | Age Factors | 8 | 2021 | 2885 | 0.650 |
Why?
| | Obstetrics | 2 | 2019 | 146 | 0.650 |
Why?
| | Hotlines | 3 | 2005 | 29 | 0.650 |
Why?
| | Analgesics | 1 | 2020 | 156 | 0.650 |
Why?
| | Policy | 1 | 2020 | 137 | 0.650 |
Why?
| | Opportunistic Infections | 1 | 2019 | 43 | 0.640 |
Why?
| | Patient Compliance | 5 | 2016 | 524 | 0.640 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 99 | 0.640 |
Why?
| | Consumer Behavior | 4 | 2014 | 65 | 0.630 |
Why?
| | Public Health Practice | 2 | 2012 | 61 | 0.620 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2018 | 24 | 0.620 |
Why?
| | Risk Assessment | 5 | 2019 | 2958 | 0.620 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 138 | 0.620 |
Why?
| | Hospitals | 2 | 2021 | 581 | 0.610 |
Why?
| | Patient Reported Outcome Measures | 1 | 2020 | 251 | 0.610 |
Why?
| | Hospital Costs | 1 | 2019 | 104 | 0.600 |
Why?
| | Public-Private Sector Partnerships | 2 | 2019 | 43 | 0.600 |
Why?
| | Vaccines, Conjugate | 3 | 2018 | 59 | 0.580 |
Why?
| | Pandemics | 3 | 2021 | 1310 | 0.580 |
Why?
| | Cooperative Behavior | 3 | 2015 | 376 | 0.580 |
Why?
| | Pregnant Women | 1 | 2019 | 129 | 0.580 |
Why?
| | Professional Practice | 1 | 2018 | 63 | 0.580 |
Why?
| | Young Adult | 17 | 2020 | 10444 | 0.570 |
Why?
| | Clinical Decision-Making | 4 | 2021 | 268 | 0.570 |
Why?
| | Public Health | 3 | 2017 | 433 | 0.560 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 126 | 0.560 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2015 | 47 | 0.560 |
Why?
| | Multivariate Analysis | 9 | 2020 | 1422 | 0.550 |
Why?
| | Diagnostic Errors | 1 | 2018 | 150 | 0.550 |
Why?
| | Cross Infection | 1 | 2019 | 194 | 0.550 |
Why?
| | Health Promotion | 2 | 2015 | 675 | 0.550 |
Why?
| | Hepatitis A | 1 | 2017 | 26 | 0.550 |
Why?
| | Physician's Role | 2 | 2019 | 192 | 0.540 |
Why?
| | Information Systems | 1 | 2016 | 61 | 0.530 |
Why?
| | Transplant Recipients | 1 | 2018 | 136 | 0.530 |
Why?
| | Cross-Sectional Studies | 13 | 2022 | 4402 | 0.530 |
Why?
| | Gastrointestinal Agents | 1 | 2016 | 60 | 0.530 |
Why?
| | Regression Analysis | 6 | 2020 | 945 | 0.520 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 212 | 0.520 |
Why?
| | Quality Assurance, Health Care | 4 | 2008 | 308 | 0.510 |
Why?
| | Health Information Systems | 1 | 2015 | 16 | 0.510 |
Why?
| | Directive Counseling | 1 | 2016 | 41 | 0.510 |
Why?
| | Universities | 2 | 2015 | 338 | 0.500 |
Why?
| | Local Government | 1 | 2015 | 29 | 0.500 |
Why?
| | Registries | 8 | 2019 | 1764 | 0.490 |
Why?
| | Immunosuppressive Agents | 1 | 2019 | 641 | 0.490 |
Why?
| | After-Hours Care | 2 | 2006 | 13 | 0.490 |
Why?
| | Spinal Fusion | 3 | 2013 | 199 | 0.490 |
Why?
| | Parental Consent | 2 | 2014 | 22 | 0.480 |
Why?
| | Communicable Diseases | 1 | 2017 | 127 | 0.480 |
Why?
| | Postnatal Care | 1 | 2015 | 65 | 0.480 |
Why?
| | Cohort Studies | 13 | 2019 | 4883 | 0.480 |
Why?
| | Ambulatory Care | 2 | 2015 | 479 | 0.470 |
Why?
| | Breast Feeding | 2 | 2010 | 366 | 0.470 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 2 | 2015 | 239 | 0.470 |
Why?
| | Private Practice | 2 | 2012 | 20 | 0.460 |
Why?
| | Community Health Services | 5 | 2018 | 212 | 0.460 |
Why?
| | Intubation, Gastrointestinal | 1 | 2014 | 54 | 0.460 |
Why?
| | Referral and Consultation | 6 | 2014 | 632 | 0.460 |
Why?
| | Documentation | 1 | 2015 | 166 | 0.450 |
Why?
| | Focus Groups | 5 | 2017 | 378 | 0.440 |
Why?
| | Public Health Administration | 1 | 2014 | 75 | 0.440 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 164 | 0.430 |
Why?
| | Disease Outbreaks | 3 | 2022 | 305 | 0.430 |
Why?
| | Enteral Nutrition | 1 | 2014 | 157 | 0.420 |
Why?
| | Postoperative Complications | 4 | 2018 | 2122 | 0.420 |
Why?
| | Safety | 2 | 2013 | 298 | 0.420 |
Why?
| | Medical Assistance | 2 | 2004 | 13 | 0.420 |
Why?
| | Risk Factors | 10 | 2019 | 8614 | 0.410 |
Why?
| | Seasons | 5 | 2020 | 440 | 0.410 |
Why?
| | Prescription Drugs | 1 | 2014 | 116 | 0.400 |
Why?
| | Aged | 12 | 2021 | 18969 | 0.400 |
Why?
| | Asthma | 7 | 2023 | 2021 | 0.400 |
Why?
| | Electronic Mail | 3 | 2018 | 54 | 0.400 |
Why?
| | Qualitative Research | 6 | 2020 | 919 | 0.390 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 18 | 0.390 |
Why?
| | Time Factors | 12 | 2015 | 6077 | 0.390 |
Why?
| | Outpatients | 1 | 2015 | 325 | 0.390 |
Why?
| | Pediatric Nursing | 2 | 2005 | 39 | 0.380 |
Why?
| | Awards and Prizes | 2 | 2012 | 56 | 0.380 |
Why?
| | Syncope | 1 | 2011 | 38 | 0.370 |
Why?
| | Costs and Cost Analysis | 4 | 2018 | 196 | 0.370 |
Why?
| | General Surgery | 1 | 2012 | 125 | 0.370 |
Why?
| | Lactic Acid | 3 | 2017 | 272 | 0.360 |
Why?
| | Laparotomy | 1 | 2011 | 101 | 0.360 |
Why?
| | Licensure, Medical | 1 | 2010 | 12 | 0.350 |
Why?
| | Albuterol | 1 | 2011 | 102 | 0.350 |
Why?
| | Drug Recalls | 1 | 2010 | 5 | 0.350 |
Why?
| | Incidence | 4 | 2019 | 2314 | 0.350 |
Why?
| | Health Surveys | 4 | 2018 | 441 | 0.350 |
Why?
| | Medical Records Systems, Computerized | 1 | 2011 | 88 | 0.350 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1204 | 0.350 |
Why?
| | Severity of Illness Index | 5 | 2020 | 2537 | 0.350 |
Why?
| | Haemophilus Vaccines | 1 | 2010 | 27 | 0.340 |
Why?
| | Haemophilus influenzae | 1 | 2010 | 48 | 0.340 |
Why?
| | Haemophilus Infections | 1 | 2010 | 28 | 0.340 |
Why?
| | Parent-Child Relations | 2 | 2015 | 235 | 0.340 |
Why?
| | Medicare Part D | 1 | 2010 | 26 | 0.340 |
Why?
| | Polysaccharides, Bacterial | 1 | 2010 | 66 | 0.340 |
Why?
| | Patient Education as Topic | 2 | 2011 | 666 | 0.330 |
Why?
| | Bacterial Outer Membrane Proteins | 1 | 2010 | 58 | 0.330 |
Why?
| | Health Policy | 3 | 2017 | 330 | 0.330 |
Why?
| | Communication | 4 | 2021 | 734 | 0.330 |
Why?
| | Pregnancy | 5 | 2020 | 5499 | 0.330 |
Why?
| | Bronchodilator Agents | 1 | 2011 | 239 | 0.320 |
Why?
| | Kidney | 1 | 2015 | 1182 | 0.310 |
Why?
| | Hepatitis B | 1 | 2009 | 51 | 0.310 |
Why?
| | Health Services Needs and Demand | 2 | 2007 | 240 | 0.310 |
Why?
| | Surgical Wound Infection | 1 | 2011 | 246 | 0.310 |
Why?
| | North Carolina | 2 | 2019 | 83 | 0.300 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 44 | 0.290 |
Why?
| | Sentinel Surveillance | 1 | 2008 | 38 | 0.290 |
Why?
| | Immunization, Secondary | 3 | 2018 | 82 | 0.290 |
Why?
| | Follow-Up Studies | 5 | 2019 | 4392 | 0.290 |
Why?
| | Medication Adherence | 3 | 2023 | 531 | 0.280 |
Why?
| | Laparoscopy | 1 | 2011 | 395 | 0.280 |
Why?
| | Treatment Outcome | 6 | 2021 | 9049 | 0.270 |
Why?
| | Sinusitis | 1 | 2009 | 174 | 0.270 |
Why?
| | Evidence-Based Medicine | 3 | 2020 | 662 | 0.260 |
Why?
| | Social Support | 1 | 2010 | 528 | 0.260 |
Why?
| | Cost of Illness | 2 | 2018 | 254 | 0.260 |
Why?
| | Office Visits | 4 | 2007 | 79 | 0.250 |
Why?
| | Length of Stay | 4 | 2015 | 957 | 0.250 |
Why?
| | Continuity of Patient Care | 2 | 2013 | 252 | 0.250 |
Why?
| | Survival Rate | 3 | 2019 | 1638 | 0.240 |
Why?
| | Prognosis | 5 | 2019 | 3315 | 0.240 |
Why?
| | Neoplasms | 1 | 2018 | 2086 | 0.230 |
Why?
| | Postal Service | 2 | 2018 | 29 | 0.230 |
Why?
| | Patient Selection | 1 | 2007 | 629 | 0.230 |
Why?
| | Depressive Disorder | 1 | 2007 | 330 | 0.230 |
Why?
| | Internet | 3 | 2019 | 591 | 0.220 |
Why?
| | Nurses | 3 | 2018 | 145 | 0.220 |
Why?
| | Health Services | 1 | 2005 | 103 | 0.220 |
Why?
| | Happiness | 1 | 2004 | 20 | 0.220 |
Why?
| | Drug Interactions | 2 | 2015 | 337 | 0.220 |
Why?
| | Statistics, Nonparametric | 2 | 2017 | 384 | 0.210 |
Why?
| | Attitude | 2 | 2021 | 228 | 0.210 |
Why?
| | Databases, Factual | 5 | 2017 | 1125 | 0.210 |
Why?
| | Comparative Effectiveness Research | 2 | 2015 | 131 | 0.210 |
Why?
| | Interviews as Topic | 3 | 2011 | 575 | 0.210 |
Why?
| | Headache | 2 | 2013 | 132 | 0.210 |
Why?
| | Urologists | 2 | 2020 | 17 | 0.200 |
Why?
| | Cholinergic Antagonists | 1 | 2022 | 27 | 0.200 |
Why?
| | Sensitivity and Specificity | 4 | 2018 | 1690 | 0.200 |
Why?
| | Brain Injuries, Traumatic | 2 | 2017 | 297 | 0.200 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2022 | 41 | 0.200 |
Why?
| | Information Centers | 1 | 2001 | 4 | 0.200 |
Why?
| | Medicare | 2 | 2018 | 661 | 0.190 |
Why?
| | Mumps Vaccine | 1 | 2021 | 13 | 0.190 |
Why?
| | Logistic Models | 5 | 2017 | 1829 | 0.190 |
Why?
| | Electronic Health Records | 2 | 2019 | 799 | 0.190 |
Why?
| | Community-Institutional Relations | 2 | 2012 | 89 | 0.190 |
Why?
| | Minority Groups | 2 | 2018 | 223 | 0.190 |
Why?
| | Community-Acquired Infections | 1 | 2022 | 139 | 0.180 |
Why?
| | Remote Consultation | 1 | 2001 | 42 | 0.180 |
Why?
| | Birth Weight | 1 | 2004 | 439 | 0.180 |
Why?
| | Herpesvirus 3, Human | 2 | 2019 | 377 | 0.180 |
Why?
| | Alphapapillomavirus | 1 | 2021 | 36 | 0.180 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 68 | 0.180 |
Why?
| | Rural Health Services | 1 | 2001 | 92 | 0.180 |
Why?
| | Anti-Vaccination Movement | 1 | 2020 | 4 | 0.180 |
Why?
| | Perception | 2 | 2017 | 309 | 0.180 |
Why?
| | Behavioral Symptoms | 1 | 2020 | 41 | 0.180 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 113 | 0.180 |
Why?
| | Psychology | 1 | 2021 | 82 | 0.180 |
Why?
| | Intussusception | 2 | 2013 | 28 | 0.170 |
Why?
| | Tetanus Toxoid | 2 | 2012 | 37 | 0.170 |
Why?
| | Norovirus | 1 | 2020 | 23 | 0.170 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 714 | 0.160 |
Why?
| | Information Services | 1 | 1999 | 42 | 0.160 |
Why?
| | Gastroenteritis | 1 | 2020 | 65 | 0.160 |
Why?
| | Child Development | 1 | 2023 | 384 | 0.160 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2020 | 119 | 0.160 |
Why?
| | Washington | 1 | 2019 | 134 | 0.160 |
Why?
| | Outpatient Clinics, Hospital | 2 | 2011 | 80 | 0.160 |
Why?
| | Serogroup | 1 | 2018 | 27 | 0.150 |
Why?
| | Hospital Mortality | 3 | 2017 | 773 | 0.150 |
Why?
| | Pharmacists | 1 | 2021 | 231 | 0.150 |
Why?
| | Camping | 1 | 1998 | 4 | 0.150 |
Why?
| | Patient Discharge | 4 | 2022 | 770 | 0.150 |
Why?
| | Stakeholder Participation | 1 | 2019 | 72 | 0.150 |
Why?
| | Allied Health Personnel | 1 | 2018 | 42 | 0.150 |
Why?
| | Australia | 2 | 2018 | 205 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2015 | 2764 | 0.150 |
Why?
| | New Zealand | 1 | 2018 | 40 | 0.150 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 60 | 0.150 |
Why?
| | Morbidity | 1 | 2019 | 277 | 0.150 |
Why?
| | Community Pharmacy Services | 1 | 2018 | 42 | 0.150 |
Why?
| | Diphtheria | 1 | 2017 | 20 | 0.150 |
Why?
| | Nuclear Family | 1 | 2018 | 48 | 0.150 |
Why?
| | Tetanus | 1 | 2017 | 25 | 0.150 |
Why?
| | Awareness | 1 | 2018 | 93 | 0.150 |
Why?
| | Health Risk Behaviors | 1 | 2017 | 13 | 0.150 |
Why?
| | Curriculum | 2 | 2015 | 813 | 0.150 |
Why?
| | Nebulizers and Vaporizers | 1 | 2018 | 77 | 0.150 |
Why?
| | Social Norms | 1 | 2017 | 21 | 0.140 |
Why?
| | Whooping Cough | 1 | 2017 | 48 | 0.140 |
Why?
| | Health Care Rationing | 2 | 2007 | 45 | 0.140 |
Why?
| | Population Groups | 1 | 2017 | 55 | 0.140 |
Why?
| | United Kingdom | 1 | 2018 | 226 | 0.140 |
Why?
| | Pneumonia | 1 | 2022 | 563 | 0.140 |
Why?
| | Infant Formula | 2 | 2010 | 74 | 0.140 |
Why?
| | Kidney Transplantation | 1 | 2023 | 538 | 0.140 |
Why?
| | Patients | 1 | 2018 | 163 | 0.140 |
Why?
| | Transplantation Immunology | 1 | 2017 | 30 | 0.140 |
Why?
| | Program Evaluation | 3 | 2007 | 820 | 0.140 |
Why?
| | Appointments and Schedules | 3 | 2019 | 70 | 0.140 |
Why?
| | Croup | 1 | 2017 | 22 | 0.140 |
Why?
| | Epilepsies, Myoclonic | 1 | 2017 | 41 | 0.140 |
Why?
| | Chi-Square Distribution | 1 | 2018 | 492 | 0.140 |
Why?
| | Professional Practice Gaps | 1 | 2016 | 9 | 0.140 |
Why?
| | Health Plan Implementation | 1 | 2018 | 132 | 0.140 |
Why?
| | Health Education | 3 | 2010 | 317 | 0.130 |
Why?
| | Infant Mortality | 1 | 1997 | 91 | 0.130 |
Why?
| | Longitudinal Studies | 2 | 2021 | 2384 | 0.130 |
Why?
| | Mobile Applications | 1 | 2018 | 140 | 0.130 |
Why?
| | Health Status Indicators | 1 | 2016 | 155 | 0.130 |
Why?
| | Neurosurgical Procedures | 1 | 2017 | 150 | 0.130 |
Why?
| | Health Personnel | 2 | 2019 | 569 | 0.130 |
Why?
| | Postoperative Period | 1 | 2016 | 288 | 0.130 |
Why?
| | Health Resources | 1 | 2017 | 120 | 0.130 |
Why?
| | Intention to Treat Analysis | 1 | 2015 | 69 | 0.130 |
Why?
| | Equipment and Supplies | 1 | 2015 | 38 | 0.130 |
Why?
| | Probability | 2 | 2007 | 286 | 0.120 |
Why?
| | Pain | 1 | 2020 | 701 | 0.120 |
Why?
| | Multiple Organ Failure | 1 | 2015 | 116 | 0.120 |
Why?
| | Cause of Death | 1 | 1997 | 362 | 0.120 |
Why?
| | Communication Barriers | 1 | 2015 | 89 | 0.120 |
Why?
| | Graft Survival | 1 | 2017 | 443 | 0.120 |
Why?
| | Research Support as Topic | 1 | 2015 | 107 | 0.120 |
Why?
| | Insurance Claim Reporting | 1 | 2014 | 21 | 0.120 |
Why?
| | Utilization Review | 1 | 2014 | 34 | 0.110 |
Why?
| | Prevalence | 1 | 2020 | 2247 | 0.110 |
Why?
| | Anti-Asthmatic Agents | 1 | 2018 | 348 | 0.110 |
Why?
| | Sex Factors | 1 | 2019 | 1706 | 0.110 |
Why?
| | Gastroenterology | 1 | 2016 | 159 | 0.110 |
Why?
| | Cluster Analysis | 1 | 2015 | 452 | 0.110 |
Why?
| | ROC Curve | 1 | 2015 | 441 | 0.110 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 175 | 0.110 |
Why?
| | Sexual Behavior | 1 | 2018 | 434 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2017 | 336 | 0.110 |
Why?
| | Patient Satisfaction | 2 | 2018 | 571 | 0.110 |
Why?
| | Specialties, Surgical | 2 | 2012 | 67 | 0.110 |
Why?
| | Mentors | 1 | 2015 | 155 | 0.110 |
Why?
| | Societies, Medical | 1 | 2017 | 655 | 0.110 |
Why?
| | Graft Rejection | 1 | 2017 | 511 | 0.110 |
Why?
| | Inpatients | 1 | 2017 | 378 | 0.110 |
Why?
| | Eligibility Determination | 2 | 2004 | 59 | 0.110 |
Why?
| | Home Nursing | 1 | 2013 | 26 | 0.110 |
Why?
| | Magnesium | 1 | 2013 | 144 | 0.110 |
Why?
| | Statistics as Topic | 1 | 2014 | 291 | 0.110 |
Why?
| | Circovirus | 1 | 2013 | 7 | 0.110 |
Why?
| | Emotions | 1 | 2017 | 474 | 0.110 |
Why?
| | Critical Care | 1 | 2017 | 472 | 0.110 |
Why?
| | Infant, Premature | 1 | 2016 | 478 | 0.100 |
Why?
| | Recovery of Function | 1 | 2016 | 573 | 0.100 |
Why?
| | Guatemala | 3 | 2019 | 267 | 0.100 |
Why?
| | Telemedicine | 1 | 2021 | 662 | 0.100 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 183 | 0.100 |
Why?
| | Drug Contamination | 1 | 2013 | 51 | 0.100 |
Why?
| | Mental Health | 1 | 1998 | 559 | 0.100 |
Why?
| | Prospective Studies | 4 | 2022 | 6195 | 0.100 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 63 | 0.100 |
Why?
| | Acute Disease | 2 | 2009 | 907 | 0.100 |
Why?
| | Mothers | 2 | 2010 | 650 | 0.100 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2013 | 117 | 0.100 |
Why?
| | Ultrasonography | 1 | 2015 | 635 | 0.100 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1791 | 0.100 |
Why?
| | Self Report | 1 | 2016 | 695 | 0.100 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2015 | 195 | 0.100 |
Why?
| | Professional Practice Location | 1 | 2011 | 26 | 0.100 |
Why?
| | Factor Analysis, Statistical | 1 | 2012 | 257 | 0.100 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 949 | 0.090 |
Why?
| | Altitude | 1 | 2015 | 435 | 0.090 |
Why?
| | Models, Organizational | 1 | 2012 | 140 | 0.090 |
Why?
| | Income | 1 | 2012 | 167 | 0.090 |
Why?
| | Schools | 1 | 2014 | 396 | 0.090 |
Why?
| | Cognition | 1 | 2018 | 990 | 0.090 |
Why?
| | Community-Based Participatory Research | 1 | 2012 | 130 | 0.090 |
Why?
| | Pharmaceutical Services | 1 | 2011 | 76 | 0.090 |
Why?
| | Organizations, Nonprofit | 1 | 2010 | 17 | 0.090 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 102 | 0.090 |
Why?
| | Swine | 1 | 2013 | 687 | 0.090 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 13 | 0.090 |
Why?
| | Down Syndrome | 1 | 2015 | 335 | 0.090 |
Why?
| | Drug Overdose | 1 | 2014 | 292 | 0.080 |
Why?
| | Drug Utilization | 1 | 2011 | 164 | 0.080 |
Why?
| | Job Satisfaction | 1 | 2011 | 168 | 0.080 |
Why?
| | Socioeconomic Factors | 3 | 2018 | 1080 | 0.080 |
Why?
| | Cystic Fibrosis | 1 | 2018 | 955 | 0.080 |
Why?
| | Odds Ratio | 1 | 2012 | 951 | 0.080 |
Why?
| | Health Expenditures | 1 | 2010 | 172 | 0.080 |
Why?
| | Pain Measurement | 1 | 2011 | 441 | 0.080 |
Why?
| | Nephrology | 1 | 2009 | 48 | 0.080 |
Why?
| | Epidemiologic Research Design | 1 | 2008 | 27 | 0.070 |
Why?
| | Efficiency, Organizational | 1 | 2008 | 126 | 0.070 |
Why?
| | Disease Management | 2 | 2017 | 556 | 0.070 |
Why?
| | Demography | 1 | 2008 | 258 | 0.070 |
Why?
| | Emigrants and Immigrants | 1 | 2009 | 107 | 0.070 |
Why?
| | Cell Phone | 2 | 2019 | 76 | 0.070 |
Why?
| | Accident Prevention | 1 | 2006 | 24 | 0.070 |
Why?
| | Diagnosis-Related Groups | 1 | 2006 | 26 | 0.070 |
Why?
| | Caregivers | 1 | 2013 | 713 | 0.070 |
Why?
| | Health Maintenance Organizations | 1 | 2006 | 93 | 0.070 |
Why?
| | Risk-Taking | 1 | 2009 | 333 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2009 | 305 | 0.060 |
Why?
| | Drug Industry | 1 | 2007 | 103 | 0.060 |
Why?
| | Bottle Feeding | 1 | 2006 | 20 | 0.060 |
Why?
| | Weight Loss | 1 | 2010 | 642 | 0.060 |
Why?
| | Surgical Procedures, Operative | 1 | 2008 | 206 | 0.060 |
Why?
| | Infant Care | 1 | 2006 | 42 | 0.060 |
Why?
| | Reference Values | 1 | 2007 | 739 | 0.060 |
Why?
| | Urban Health | 1 | 2005 | 73 | 0.060 |
Why?
| | France | 1 | 2005 | 28 | 0.060 |
Why?
| | Rural Health | 1 | 2005 | 67 | 0.060 |
Why?
| | Mass Media | 1 | 2005 | 37 | 0.060 |
Why?
| | Office Automation | 1 | 2004 | 4 | 0.060 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 489 | 0.060 |
Why?
| | Policy Making | 1 | 2004 | 80 | 0.060 |
Why?
| | Counseling | 1 | 2006 | 342 | 0.060 |
Why?
| | History, 20th Century | 1 | 2005 | 265 | 0.060 |
Why?
| | Hospitalists | 1 | 2007 | 172 | 0.060 |
Why?
| | Philadelphia | 1 | 2003 | 47 | 0.050 |
Why?
| | Aged, 80 and over | 2 | 2011 | 6306 | 0.050 |
Why?
| | Medical Indigency | 1 | 2003 | 11 | 0.050 |
Why?
| | Anti-Bacterial Agents | 2 | 2022 | 1471 | 0.050 |
Why?
| | Florida | 1 | 2003 | 73 | 0.050 |
Why?
| | Ohio | 1 | 2003 | 135 | 0.050 |
Why?
| | Play and Playthings | 1 | 2023 | 30 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2004 | 116 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2009 | 592 | 0.050 |
Why?
| | Language Development | 1 | 2023 | 58 | 0.050 |
Why?
| | Patient Care Team | 1 | 2007 | 517 | 0.050 |
Why?
| | Quality of Life | 2 | 2023 | 2343 | 0.050 |
Why?
| | Interprofessional Relations | 1 | 2004 | 246 | 0.050 |
Why?
| | Education, Medical | 1 | 2005 | 214 | 0.050 |
Why?
| | Regional Medical Programs | 1 | 2001 | 4 | 0.050 |
Why?
| | Linear Models | 1 | 2004 | 768 | 0.050 |
Why?
| | Fever | 1 | 2022 | 280 | 0.050 |
Why?
| | Aftercare | 1 | 2022 | 186 | 0.050 |
Why?
| | Hospitals, Rural | 1 | 2000 | 31 | 0.050 |
Why?
| | Living Donors | 1 | 2023 | 270 | 0.040 |
Why?
| | Language | 1 | 2023 | 263 | 0.040 |
Why?
| | Private Sector | 1 | 2000 | 51 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 102 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2007 | 3003 | 0.040 |
Why?
| | Evaluation Studies as Topic | 1 | 2000 | 167 | 0.040 |
Why?
| | Wounds and Injuries | 1 | 2006 | 674 | 0.040 |
Why?
| | Databases as Topic | 1 | 1999 | 63 | 0.040 |
Why?
| | Maternal Age | 1 | 2019 | 116 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2021 | 316 | 0.040 |
Why?
| | Nursing Staff, Hospital | 1 | 2000 | 123 | 0.040 |
Why?
| | Obesity | 1 | 2010 | 2505 | 0.040 |
Why?
| | Eggs | 1 | 1998 | 29 | 0.040 |
Why?
| | Health Status | 1 | 2003 | 716 | 0.040 |
Why?
| | Nursing Assessment | 1 | 1998 | 47 | 0.040 |
Why?
| | Nurse-Patient Relations | 1 | 1998 | 43 | 0.040 |
Why?
| | Social Class | 1 | 1999 | 205 | 0.040 |
Why?
| | Health Behavior | 1 | 2023 | 701 | 0.040 |
Why?
| | NAV1.1 Voltage-Gated Sodium Channel | 1 | 2017 | 15 | 0.040 |
Why?
| | Educational Status | 1 | 2019 | 408 | 0.040 |
Why?
| | Veins | 1 | 2017 | 55 | 0.030 |
Why?
| | Neonatal Screening | 1 | 2018 | 151 | 0.030 |
Why?
| | Drug Hypersensitivity | 1 | 1998 | 83 | 0.030 |
Why?
| | Palivizumab | 1 | 2016 | 13 | 0.030 |
Why?
| | Glasgow Coma Scale | 1 | 2017 | 151 | 0.030 |
Why?
| | Liver Failure | 1 | 2016 | 73 | 0.030 |
Why?
| | Organ Dysfunction Scores | 1 | 2015 | 39 | 0.030 |
Why?
| | Arteries | 1 | 2017 | 246 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1218 | 0.030 |
Why?
| | Canada | 1 | 2016 | 320 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2018 | 735 | 0.030 |
Why?
| | Hypotension | 1 | 2015 | 115 | 0.030 |
Why?
| | Direct Service Costs | 1 | 2014 | 10 | 0.030 |
Why?
| | Food Hypersensitivity | 1 | 1998 | 251 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2013 | 198 | 0.030 |
Why?
| | Community Mental Health Services | 1 | 2013 | 82 | 0.030 |
Why?
| | Comorbidity | 1 | 2017 | 1447 | 0.030 |
Why?
| | Risk | 1 | 2015 | 810 | 0.030 |
Why?
| | Migraine Disorders | 1 | 2013 | 82 | 0.030 |
Why?
| | Sleep | 1 | 2017 | 631 | 0.020 |
Why?
| | Accreditation | 1 | 2012 | 76 | 0.020 |
Why?
| | Disease Progression | 1 | 2018 | 2371 | 0.020 |
Why?
| | Animals | 1 | 2013 | 31565 | 0.020 |
Why?
| | Certification | 1 | 2012 | 84 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 2784 | 0.020 |
Why?
| | Education, Medical, Graduate | 1 | 2012 | 366 | 0.020 |
Why?
| | Healthy People Programs | 1 | 2007 | 8 | 0.020 |
Why?
| | Pilot Projects | 1 | 2012 | 1360 | 0.020 |
Why?
| | Mutation | 1 | 2017 | 3338 | 0.020 |
Why?
| | Domestic Violence | 1 | 2006 | 41 | 0.020 |
Why?
| | Biomarkers | 1 | 2015 | 3397 | 0.020 |
Why?
| | Quality Indicators, Health Care | 1 | 2008 | 285 | 0.020 |
Why?
| | Renal Dialysis | 1 | 2009 | 375 | 0.020 |
Why?
| | Postoperative Care | 1 | 2007 | 223 | 0.020 |
Why?
| | Survival Analysis | 1 | 2008 | 1206 | 0.010 |
Why?
| | Orthopedics | 1 | 2007 | 120 | 0.010 |
Why?
| | Preoperative Care | 1 | 2007 | 319 | 0.010 |
Why?
| | Cost Control | 1 | 2004 | 39 | 0.010 |
Why?
| | Internship and Residency | 1 | 2013 | 920 | 0.010 |
Why?
| | Directly Observed Therapy | 1 | 2004 | 14 | 0.010 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2006 | 227 | 0.010 |
Why?
| | Patient Care | 1 | 2004 | 99 | 0.010 |
Why?
| | Schools, Medical | 1 | 2004 | 121 | 0.010 |
Why?
| | Research | 1 | 2004 | 389 | 0.010 |
Why?
| | Hospital Records | 1 | 2000 | 10 | 0.010 |
Why?
| | Contraindications | 1 | 1998 | 84 | 0.010 |
Why?
|
|
Kempe's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|